Dana dhuwit saben siji saham Caribou Biosciences, Inc (CRBU)

Simbol lan logo merek Caribou Biosciences, Inc (CRBU)

Free cash flow per share in the trend on the GURU.Markets chart demonstrates liquidity dynamics, where the value 0.87 represents the current metric. Caribou Biosciences (CRBU) is optimizing center energy costs and processing bioplastics. However, the business faces patent litigation and a need for massive capital. The stability of the R&D core is ensured by aggressive headhunting and stock options for rare genetic engineers.

CRBU Caribou Biosciences Inc.: Dhuwit awis saben siji saham ing interval 04.07.2022 - 21.11.2026

Rincian metrik komprehensif lan analitis Caribou Biosciences, Inc. (CRBU)

Ringkesan analisis perusahaan:CRBU (Caribou Biosciences, Inc)
Produk dadi cariboubio.com

Caribou Biosciences (CRBU) utilizes proprietary chRDNA technology to develop CAR-T therapies under strict FDA oversight. By analyzing changes in cash per share, an investor can track the daily proportion of liquid reserves per security, enabling an assessment of the issuer's financial stability and the balance between capital security and the efficiency of market expansion investments.